[1]
“IN-VITRO SUSCEPTIBILITY OF OXACILLIN, VANCOMYCIN AND TEICOPLANIN AGAINST CLINICAL STRAINS OF STAPHYLOCOCCI”, Int J of Biomed & Adv Res, vol. 1, no. 4, pp. 126–129, Dec. 2010, doi: 10.7439/ijbar.v1i4.11.